Immunosuppression in toxoplasmosis: studies in mice with a clostridial vaccine and louping-ill virus vaccine.
D000818:Animals; D000906:Antibodies / Q000032:analysis; D000907:Antibodies, Bacterial / Q000032:analysis; D000914:Antibodies, Viral / Q000032:analysis; D000917:Antibody Formation; D001428:Bacterial Vaccines / Q000276:immunology*; D003016:Clostridium perfringens / Q000276:immunology*; D004669:Encephalitis Viruses, Tick-Borne / Q000276:immunology*; D007165:Immunosuppression Therapy; D051379:Mice / Q000276:immunology*; D014122:Toxoplasma / Q000276:immunology; D014124:Toxoplasmosis, Animal / Q000276:immunology*; D014765:Viral Vaccines / Q000276:immunology*
D000906:Antibodies; D000907:Antibodies, Bacterial; D000914:Antibodies, Viral; D001428:Bacterial Vaccines; D014765:Viral Vaccines